 Wall Street brokerages expect Ascendis Pharma AS NASDAQ:ASND to post sales of 1.94 million for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Ascendis Pharma ASs earnings, with the lowest sales estimate coming in at 1.18 million and the highest estimate coming in at 2.95 million. Ascendis Pharma AS ... 